NASDAQ:SONN
Delisted

Sonnet Biotherapeutics Holdings Stock Forecast

etoro logo Buy SONN
*Your capital is at risk
$1.26
+0 (+0%)
At Close: Feb 27, 2026

SONN Performance

FAQ

What is the symbol for Sonnet Biotherapeutics Holdings Inc. Stock and on which exchange is it traded?
The symbol for Sonnet Biotherapeutics Holdings Inc. is SONN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sonnet Biotherapeutics Holdings Inc. Stock?
Sonnet Biotherapeutics Holdings Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Sonnet Biotherapeutics Holdings Inc. Stock?
Sonnet Biotherapeutics Holdings Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sonnet Biotherapeutics Holdings Inc. Stock.

What's the current price of Sonnet Biotherapeutics Holdings Inc. Stock?
As of the end of day on the Feb 27, 2026, the price of an Sonnet Biotherapeutics Holdings Inc. (SONN) share was $1.26.

What is the 52-week high and low for Sonnet Biotherapeutics Holdings Inc. Stock?
The 52-week high for Sonnet Biotherapeutics Holdings Inc. Stock is $18.86 and the 52-week low is $1.08.

What is the market capitalization of Sonnet Biotherapeutics Holdings Inc. Stock?
As of the Feb 27, 2026, the market capitalization of Sonnet Biotherapeutics Holdings Inc. is 8.434M.
Click to get the best stock tips daily for free!
ABOUT SONNET BIOTHERAPEUTICS HOLDINGS INC.
Sonnet Biotherapeutics Holdings
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the ...
GOLDEN STAR
Ticker Change Signal Date

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE